Breast cancer chemotherapy before surgery mainly adopts neoadjuvant chemotherapy, which can help subsequent surgery, radiation therapy and so on.
Clinically, some breast cancer patients are treated with chemotherapy first mainly with neoadjuvant chemotherapy which can make the breast lump shrink and kill metastatic cells early, which can help subsequent surgical resection, radiation therapy and so on, and can improve the therapeutic effect. Usually, neoadjuvant chemotherapy is suitable for breast cancer patients with large breast lumps, axillary lymph node metastasis, and breast cancer patients who have the will to preserve breasts but the tumor size is large and difficult to preserve breasts.
For breast cancer neoadjuvant chemotherapy, anthracycline drugs such as doxorubicin and epirubicin, and drugs such as paclitaxel and docetaxel are mainly applied. In addition to neoadjuvant chemotherapy, breast cancer patients can also undergo chemotherapy after surgery, the main purpose of which is to kill the tiny lesions that cannot be eliminated by surgery, which can help to reduce the metastasis and recurrence of cancerous lesions, and also improve the survival rate of patients.
It is suggested that diagnosed breast cancer patients should adjust their mindset and actively cooperate with doctors in order to control their condition and improve their quality of life.
Please strictly follow the doctor’s prescription for medication and do not use medication on your own.